{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:22:59Z","timestamp":1770506579362,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.cllc.2014.06.008","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T13:30:11Z","timestamp":1403616611000},"page":"433-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Strategies to Prevent Brain Metastasis in High-Risk Non\u2013Small-Cell Lung Cancer: Lessons Learned From a Randomized Study of Maintenance Temozolomide Versus Observation"],"prefix":"10.1016","volume":"15","author":[{"given":"D. Hunter","family":"Boggs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Ian","family":"Robins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey J.","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Traynor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice J.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minesh P.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2014.06.008_bib1","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1200\/JCO.1999.17.9.2700","article-title":"Prophylactic cranial irradiation in locally advanced non-small cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects","volume":"17","author":"Stuschke","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lungcan.2004.12.004","article-title":"Does the incidence and outcome of\u00a0brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?","volume":"49","author":"Carolan","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2014.06.008_bib3","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jnci\/djr325","article-title":"Phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III non-small cell lung cancer (NSCLC): report of Radiation Therapy Oncology Group (RTOG) 9410","volume":"103","author":"Curran","year":"2011","journal-title":"J\u00a0Natl Can Inst"},{"key":"10.1016\/j.cllc.2014.06.008_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0360-3016(98)00429-5","article-title":"Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of Radiation Therapy Oncology Group (RTOG) trials","volume":"43","author":"Cox","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2014.06.008_bib5","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib6","first-page":"1","article-title":"Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis","volume":"15","author":"Meert","year":"2001","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cllc.2014.06.008_bib7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJM199908123410703","article-title":"Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group","volume":"341","author":"Aup\u00e9rin","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2014.06.008_bib8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa071780","article-title":"Prophylactic cranial irradiation in extensive small-cell lung cancer","volume":"357","author":"Slotman","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2014.06.008_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.2008.17.0746","volume":"27","author":"Slotman","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib10","first-page":"127","article-title":"Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on management","volume":"2","author":"Kanard","year":"2004","journal-title":"J\u00a0Support Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2010.29.1609","article-title":"Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214","volume":"29","author":"Gore","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.2010.29.6053","article-title":"Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non\u2013small-cell lung cancer: neurocognitive and quality-of-life analysis","volume":"29","author":"Sun","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib13","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1200\/JCO.2007.12.5468","article-title":"Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial","volume":"25","author":"P\u00f6ttgen","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.1981.03310300023013","article-title":"Cranial irradiation in cancer of the lung of all cell types","volume":"245","author":"Cox","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.cllc.2014.06.008_bib15","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ijrobp.2005.03.030","article-title":"Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: a Cochrane Review","volume":"63","author":"Lester","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2014.06.008_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00253278","article-title":"Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer","volume":"2","author":"Umsawasdi","year":"1984","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2014.06.008_bib18","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1158\/1078-0432.CCR-03-0807","article-title":"Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients","volume":"10","author":"Ostermann","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2014.06.008_bib19","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1200\/JCO.2002.04.140","article-title":"Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases","volume":"20","author":"Antonadou","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0360-3016(02)03217-0","article-title":"Whole brain radiotherapy alone or in combination with temozolomide for brain metastasis. A phase III study","volume":"54","author":"Antonadou","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2014.06.008_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijrobp.2004.04.061","article-title":"Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial","volume":"61","author":"Verger","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2014.06.008_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1012226718323","article-title":"A\u00a0phase II trial of temozolomide for patients with recurrent or progressive brain metastases","volume":"53","author":"Abrey","year":"2011","journal-title":"J\u00a0Neurooncol"},{"issue":"4 Suppl 13","key":"10.1016\/j.cllc.2014.06.008_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0093-7754(01)90069-7","article-title":"Temozolomide for treating brain metastases","volume":"28","author":"Abrey","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3816\/CLC.2002.n.009","article-title":"Temozolomide in non-small-cell lung cancer: preliminary results of a phase II trial in previously treated patients","volume":"3","author":"Adonzio","year":"2002","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cllc.2014.06.008_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1556-0864(15)31575-6","article-title":"Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer","volume":"1","author":"Choong","year":"2006","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib26","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1200\/JCO.1997.15.8.2850","article-title":"Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial","volume":"15","author":"Tannehill","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0360-3016(91)90681-S","article-title":"Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group","volume":"21","author":"Russell","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2014.06.008_bib28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.lungcan.2004.01.025","article-title":"Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma","volume":"45","author":"Bajard","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2014.06.008_bib29","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/1097-0142(20010615)91:12<2394::AID-CNCR1273>3.0.CO;2-6","article-title":"Patterns of relapse of N2 non-small cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered?","volume":"91","author":"Andre","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2014.06.008_bib30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/cncr.10687","article-title":"Brain metastases in locally advanced non-small cell lung carcinoma after multimodality treatment: risk factors analysis","volume":"95","author":"Ceresoli","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2014.06.008_bib31","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1200\/JCO.2001.19.5.1344","article-title":"Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma","volume":"19","author":"Robnett","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl","key":"10.1016\/j.cllc.2014.06.008_bib32","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.ijrobp.2013.06.1388","article-title":"Predictive factors for brain metastases and relapse and prognostic factors for survival in stage II-IV non-small cell lung cancer (NSCLC)","volume":"87","author":"Yoon","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2014.06.008_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2407-9-119","article-title":"Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis","volume":"9","author":"Arrieta","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cllc.2014.06.008_bib34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ejcts.2009.08.005","article-title":"Vascular endothelial growth factor C: the predicator of early recurrence in patients with N2 non-small-cell lung cancer","volume":"37","author":"Chen","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cllc.2014.06.008_bib35","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0959-8049(03)00234-X","article-title":"Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965)","volume":"39","author":"Dziadziuszko","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2014.06.008_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.lungcan.2005.05.026","article-title":"Oral temozolomide in heavily pre-treated brain metastases from non-small cell lung cancer: phase II study","volume":"50","author":"Giorgio","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2014.06.008_bib37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/annonc\/mdp343","article-title":"Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study","volume":"21","author":"Siena","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1200\/JCO.2004.05.128","article-title":"Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial","volume":"22","author":"Meyers","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib39","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","author":"Aoyama","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cllc.2014.06.008_bib40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.10712","article-title":"Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life","volume":"54","author":"Klein","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cllc.2014.06.008_bib41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00213-003-1540-9","article-title":"Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers","volume":"170","author":"Zacny","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.cllc.2014.06.008_bib42","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib43","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2006.09.2536","article-title":"Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function","volume":"25","author":"Li","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2010.02.030","article-title":"Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933","volume":"95","author":"Gondi","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib45","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ijrobp.2008.03.009","article-title":"Memory function before and after whole brain radiotherapy in patients with and without brain metastases","volume":"72","author":"Welzel","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2014.06.008_bib46","first-page":"4021","article-title":"Extreme sensitivity of adult neurogenesis to low doses of X irradiation","volume":"63","author":"Mizumatsu","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2014.06.008_bib47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1667\/RR3206","article-title":"Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis","volume":"162","author":"Raber","year":"2004","journal-title":"Radiat Res"},{"key":"10.1016\/j.cllc.2014.06.008_bib48","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0360-3016(94)00550-8","article-title":"Neuropsychological effects of cranial radiation: current knowledge and future directions","volume":"31","author":"Roman","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2014.06.008_bib49","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2012.11.031","article-title":"Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors","volume":"85","author":"Gondi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2014.06.008_bib50","article-title":"Memory preservation with conformal avoidance of the hippocampus during whole-brain radiotherapy (WBRT) for patients with brain metastasis: preliminary results of RTOG 0933","volume":"15","author":"Gondi","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib51","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1200\/JCO.2002.07.500","article-title":"Lead-in phase to randomized trial of motexafin gadolinium and whole brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points","volume":"20","author":"Mehta","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib52","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2003.12.122","article-title":"Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases","volume":"21","author":"Mehta","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2014.06.008_bib53","unstructured":"U.S. National Institutes of Health. Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer. ClinicalTrials.gov summary. Available at: http:\/\/clinicaltrials.gov\/show\/NCT01797159. Accessed November 2,\u00a02013."}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730414001211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730414001211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:04:37Z","timestamp":1761505477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730414001211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1525730414001211"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2014.06.008","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies to Prevent Brain Metastasis in High-Risk Non\u2013Small-Cell Lung Cancer: Lessons Learned From a Randomized Study of Maintenance Temozolomide Versus Observation","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2014.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}